References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Wittmanetal(2005)Discoveryofa(1H-benzoimidazol-2-yl)-1H-pyridin-2-one(BMS-536924)inhibitorofinsulin-likegrowthfactorIreceptorkinasewithinvivoantitumoractivity.J.Med.Chem.485639PMID:16134929
Huangetal(2009)Themechanismsofdifferentialsensitivitytoaninsulin-likegrowthfactor-1receptorinhibitor(BMS-536924)andrationaleforcombiningwithEGFR/HER2inhibitors.CancerRes.69161PMID:19117999
Hendricksonetal(2009)ExpressionofinsulinreceptorisoformAandinsulin-likegrowthfactor-1receptorinhumanacutemyelogenousleukemia:effectofthedual-receptorinhibitorBMS-536924invitro.CancerRes.697635PMID:19789352
Kimetal(2007)ConstitutivelyactivetypeIinsulin-likegrowthfactorreceptorcausestransformationandxenograftgrowthofimmortalizedmammaryepithelialcellsandisaccompaniedbyanepithelial-to-mesenchymaltransitionmediatedbyNF-κ273165PMID:17296734
Keywords:BMS536924,supplier,BMS536924,antitumor,antiproliferatives,insulin,receptor,IR,insulin-like,growth,factor-1,receptor,IGF1R,dual,inhibitors,inhibits,EMT,epithelial-to-mesenchymal,transition,Insulin,and,insulin-like,Receptors,Insulin,and,Insulin-like,Receptors,Insulin,and,insulin-like,Receptors,TocrisBioscience